Key result
Transseptal mitral surgery is linked to ~44% higher PPM risk versus left atrial approach.
Why the study?
The optimal surgical access for mitral valve surgery remains debated, as studies report differing perioperative and postoperative outcomes between transseptal and left atrial approaches.
Does the transseptal approach increase the risk of permanent pacemaker implantation compared to the left atrial approach in patients undergoing mitral valve surgery?
Meta-Analysis
Does the transseptal approach increase the risk of permanent pacemaker implantation compared to the left atrial approach in patients undergoing mitral valve surgery?
The transseptal approach for mitral valve surgery is associated with longer operative times and a significantly higher risk of postoperative conduction disturbances and permanent pacemaker implantation compared to the left atrial approach.
Answers are grounded in this paper and cite their sources.
TS approach linked to longer operative times and higher pacemaker risk than LA in MVS; extends pooled evidence favoring LA to minimize complications.
Objective Surgical access to the mitral valve can be achieved through various techniques, with the transseptal (TS) and left atrial (LA) approaches being the most commonly used in mitral valve surgery (MVS). However, the optimal approach remains a subject of debate, as studies report differing perioperative and postoperative outcomes associated with each technique. This meta-analysis aims to systematically compare the clinical outcomes of TS versus LA approaches in MVS. Methods This meta-analysis followed the PRISMA guidelines. A comprehensive literature search of PubMed, Embase and Scopus databases was performed until June 2025. The primary outcome was permanent pacemaker (PPM) implantation. Results Twenty-five studies were included. The TS approach was associated with higher risk of PPM implantation (risk ratio: 1.44, 95% confidence interval [1.07–1.95]; P = 0.01), postoperative atrial fibrillation, postoperative junctional rhythm, atrioventricular block, need for temporary pacing and longer cardiopulmonary bypass time, aortic cross-clamp time (CCT), hospital-stay and bleeding. No significant differences were found in intensive care unit stay, mortality, infections, stroke and renal failure. Subgroup analysis of isolated MVS showed no differences in most outcomes except for a higher risk of PPM implantation and postoperative atrial fibrillation in the TS group. Conclusion Our meta-analysis demonstrates that the TS approach is associated with longer operative times and a higher risk of postoperative conduction disturbances and PPM implantation. However, no significant differences were observed in other major clinical outcomes. These findings do not support the overall superiority of either approach, and surgical access should be individualized according to patient anatomy, procedural requirements, and surgeon experience. Further high-quality studies are needed to strengthen the available evidence.
No takes yet. Share an insight, caveat, or question.
Paramkusam et al. (2026) conducted a meta-analysis in Mitral valve surgery. Transseptal (TS) approach vs. Left atrial (LA) approach was evaluated on Permanent pacemaker (PPM) implantation (RR 1.44, 95% CI 1.07-1.95, p=0.01). The transseptal approach for mitral valve surgery was associated with a higher risk of permanent pacemaker implantation compared to the left atrial approach.
Synapse has enriched 10 related papers. Consider them for comparative context: